Literature DB >> 25728697

Functional gastrointestinal disorders in 35,447 adults and their association with body mass index.

D Le Pluart1, J-M Sabaté, M Bouchoucha, S Hercberg, R Benamouzig, C Julia.   

Abstract

BACKGROUND: Functional gastrointestinal disorders' (FGIDs) associations with body mass index (BMI) have not been thoroughly investigated in the general population. AIM: To investigate the overlap between functional dyspepsia (FDy), irritable bowel syndrome (IBS), functional constipation (FC) and functional diarrhoea (FDh) and the relationship between BMI and those diagnoses in a large French adult population.
METHODS: Subjects participating in the Nutrinet-Santé cohort study completed a questionnaire based on Rome III criteria. Anthropometrics, socio-demographical and lifestyle data were collected via self-administered questionnaires. Associations between BMI and FGIDs were investigated with multivariate logistic regression.
RESULTS: A total of 35 447 subjects were included in the analysis. Among subjects with FGIDs, 10.4% presented more than one disorder. [FDy coexisted with IBS (23.6%) and FC (15.1%)]. Associations between BMI and FDy differed according to sex. In females, higher odds were observed for underweight and obesity subgroups (OR = 1.26 (95% CI: 0.99-1.59), OR = 1.35 (1.08-1.69), OR = 1.20 (0.81-1.77), OR = 1.47 (0.89-2.42) for underweight, class I, II and III obesity respectively compared with normal BMI), forming a U-shaped relationship confirmed with nonlinear model (P < 0.001). In females, FDh was associated with BMI [OR = 1.05 (1.03-1.07), P < 0.001]. In males, a negative association between BMI and IBS was observed [OR = 0.97 (0.94-0.99), P=0.04]. Other associations were not significant.
CONCLUSIONS: Our study showed an important overlap in FGIDs, supporting the contention of common pathophysiological mechanisms. Relationships between BMI and FGIDs appeared to be sex-dependent. Interaction by sex in the association between BMI and FGIDs should therefore be further explored.
© 2015 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25728697     DOI: 10.1111/apt.13143

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  30 in total

1.  Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source.

Authors:  Michel Bouchoucha; Marinos Fysekidis; Chantal Julia; Gheorghe Airinei; Jean-Marc Catheline; Gérard Reach; Robert Benamouzig
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

Review 2.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

3.  Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors.

Authors:  Luca Antonioli; Carolina Pellegrini; Matteo Fornai; Erika Tirotta; Daniela Gentile; Laura Benvenuti; Maria Cecilia Giron; Valentina Caputi; Ilaria Marsilio; Genny Orso; Nunzia Bernardini; Cristina Segnani; Chiara Ippolito; Balázs Csóka; Zoltán H Németh; György Haskó; Carmelo Scarpignato; Corrado Blandizzi; Rocchina Colucci
Journal:  Purinergic Signal       Date:  2017-08-14       Impact factor: 3.765

4.  Difficult defecation in constipated patients and its relationship to colonic disorders.

Authors:  Michel Bouchoucha; Ghislain Devroede; Cyriaque Bon; Florence Mary; Baktiar Bejou; Robert Benamouzig
Journal:  Int J Colorectal Dis       Date:  2016-02-09       Impact factor: 2.571

5.  Association between body mass index and irritable bowel syndrome in the young Japanese population: a cross-sectional study.

Authors:  Yasunori Yamamoto; Shinya Furukawa; Junichi Watanabe; Aki Kato; Katsunori Kusumoto; Teruki Miyake; Eiji Takeshita; Yoshio Ikeda; Naofumi Yamamoto; Yuka Saeki; Yoichi Hiasa
Journal:  Int J Colorectal Dis       Date:  2022-10-20       Impact factor: 2.796

Review 6.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

7.  Breath methane concentrations and markers of obesity in patients with functional gastrointestinal disorders.

Authors:  Clive H Wilder-Smith; Søren S Olesen; Andrea Materna; Asbjørn M Drewes
Journal:  United European Gastroenterol J       Date:  2017-11-15       Impact factor: 4.623

Review 8.  Functional dyspepsia: new insights into pathogenesis and therapy.

Authors:  Nicholas J Talley
Journal:  Korean J Intern Med       Date:  2016-04-06       Impact factor: 2.884

9.  Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity.

Authors:  Luca Antonioli; Valentina Caputi; Matteo Fornai; Carolina Pellegrini; Daniela Gentile; Maria Cecilia Giron; Genny Orso; Nunzia Bernardini; Cristina Segnani; Chiara Ippolito; Balázs Csóka; György Haskó; Zoltán H Németh; Carmelo Scarpignato; Corrado Blandizzi; Rocchina Colucci
Journal:  Int J Obes (Lond)       Date:  2018-08-06       Impact factor: 5.095

10.  Abdominal Pain Severity Is Mainly Associated with Bloating Severity in Patients with Functional Bowel Disorders and Functional Abdominal Pain.

Authors:  David Deutsch; Michel Bouchoucha; Julien Uzan; Jean-Jacques Raynaud; Jean-Marc Sabate; Robert Benamouzig
Journal:  Dig Dis Sci       Date:  2021-07-29       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.